Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126445903 | 12644590 | 3 | F | 20160311 | 20160916 | 20160811 | 20160926 | EXP | US-TEVA-682047USA | TEVA | 57.68 | YR | F | Y | 0.00000 | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126445903 | 12644590 | 1 | PS | BACLOFEN. | BACLOFEN | 1 | Oral | 100 MILLIGRAM DAILY; | 72234 | 100 | MG | QD | |||||||
| 126445903 | 12644590 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 20 MILLIGRAM DAILY; | 0 | 10 | MG | TABLET | BID | ||||||
| 126445903 | 12644590 | 3 | SS | AMPYRA | DALFAMPRIDINE | 1 | 0 | ||||||||||||
| 126445903 | 12644590 | 4 | SS | TIZANIDINE. | TIZANIDINE | 1 | 4 MILLIGRAM DAILY; HS | U | 0 | 4 | MG | CAPSULE | QD | ||||||
| 126445903 | 12644590 | 5 | C | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | .5 MILLIGRAM DAILY; | 0 | .5 | MG | QD | ||||||||
| 126445903 | 12644590 | 6 | C | RESTASIS | CYCLOSPORINE | 1 | 0 | ||||||||||||
| 126445903 | 12644590 | 7 | C | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MILLIGRAM DAILY; | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126445903 | 12644590 | 2 | Gait disturbance |
| 126445903 | 12644590 | 3 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126445903 | 12644590 | HO |
| 126445903 | 12644590 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126445903 | 12644590 | Fatigue | |
| 126445903 | 12644590 | Haematoma | |
| 126445903 | 12644590 | Injury associated with device | |
| 126445903 | 12644590 | Loss of consciousness | |
| 126445903 | 12644590 | Withdrawal syndrome | |
| 126445903 | 12644590 | Wound infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |